MedTrace Logo

The Effect of Polymorphism of the GUCY1A3 rs7692387 Gene on Cardiovascular Events After Coronary Artery Bypass Grafting.

NCT06215300 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2024-01-22

No results posted yet for this study

Summary

Polymorphism in the GUCY1A3 gene worsens the activity of rCC, causing vasoconstriction and increased platelet aggregation. Studies have shown the association of the GUCY1A3 gene with the risk of coronary heart disease and its complications, with ischemic stroke

Conditions

  • to Evaluate the Association of GUCY1A3 rs7692387 Gene Polymorphism Carrier on the Development of Cardiovascular Events After Coronary Artery Bypass Grafting

Interventions

GENETIC

coronary artery bypass grafting

coronary artery bypass grafting

Sponsors & Collaborators

  • Novosibirsk Scientific Research Institute for Circulatory Pathology

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-01
Primary Completion
2025-11-01
Completion
2025-11-01

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06215300 on ClinicalTrials.gov